Tutorials
Step 1: Confirm presence of Pseudomonas aeruginosa
Step 2: Assessment for clinical deterioration
Step 3: First line and second line treatment
Step 4: Prevent future exacerbations
Tobramycin dosing for use in non-CF bronchiectasis
The incidence of bronchiectasis in Wales is increasing, and improving the management of exacerbations for these patients will have a big impact on their quality of life and mortality.
The right place for many patients experiencing an exacerbation of their bronchiectasis is at home; they are much safer and can be equipped to receive intravenous antibiotics at home.
An initiative in Wales to standardise the approach of managing these patients, ideally in the community, comes in the form of the All-Wales Pathway for Managing Adult non-CF Bronchiectasis Patients with Pseudomonas Aeruginosa Infection in the Community.
